# Comparison of Subject-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Twice Daily Versus Investigator-driven Titration of BIAsp 30 Twice Daily Both in Combination With Oral Antidiabetic Drugs in Subjects With Type 2 Diabetes

Study · id `cardio:ct-nct01618214` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01618214](<https://clinicaltrials.gov/study/NCT01618214>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01618214

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 344 participants.

## Technical summary

Registry record NCT01618214. Randomized; no masking; primary purpose treatment. Start 2012-06 (registry gives no type); primary completion 2013-01 (actual). Results posted on 2014-05-08.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 344 participants (enrolled count; ClinicalTrials.gov record NCT01618214, source copy `cardio:ctgov-nct01618214-2017-02-24`, retrieved 2026-10-26)
- Start date: 2012-06 (registry gives no type) (ClinicalTrials.gov record NCT01618214, source copy `cardio:ctgov-nct01618214-2017-02-24`, retrieved 2026-10-26)
- Primary completion: 2013-01 (actual) (ClinicalTrials.gov record NCT01618214, source copy `cardio:ctgov-nct01618214-2017-02-24`, retrieved 2026-10-26)
- Completion: 2013-01 (actual) (ClinicalTrials.gov record NCT01618214, source copy `cardio:ctgov-nct01618214-2017-02-24`, retrieved 2026-10-26)
- Results first posted: 2014-05-08 (ClinicalTrials.gov record NCT01618214, source copy `cardio:ctgov-nct01618214-2017-02-24`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT01618214, source copy `cardio:ctgov-nct01618214-2017-02-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01618214-2017-02-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of Subject-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Twice Daily Versus Investigator-driven Titration of BIAsp 30 Twice Daily Both in Combination With Oral Antidiabetic Drugs in Subjects With Type 2 Diabetes
- Condition: Diabetes
- Condition: Diabetes Mellitus, Type 2
- Intervention (Drug): biphasic insulin aspart 30
- Lead sponsor: Novo Nordisk A/S
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Novo Nordisk (`cardio:novo-nordisk`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: Subject-driven titration of biphasic insulin aspart 30 twice daily is non-inferior to investigator-driven titration in Chinese patients with type 2 diabetes inadequately controlled with premixed human insulin: A randomized, open-label, parallel-group, multicenter trial (`cardio:pubmed-26816605`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: a331ccd30120e9757fdaf75b71a1a89b66ce22ce8a47b1268b74f44442a43410
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
